Glaxosmithkline Share News (GSK)

LONDON BROKER RATINGS: BofA lifts Lloyds to 'buy' from 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday:

Unilever warns of more price hikes as cost pressures build

April 28 (Reuters) - Unilever raised prices by over 8% in the first quarter and warned more hikes were on the way as the maker of Dove soap and Ben & Jerry's ice cream lifted its cost inflation forecast for the second half of the year due to the Ukraine conflict.

LONDON BRIEFING: UK consumer firms warn of "unprecedented inflation"

(Alliance News) - As the first quarter earnings season reached a peak on Thursday, a string of UK companies warned that rampant inflation will hurt profit margins and force them to raise prices to consumers.

LONDON MARKET CLOSE: Stocks mixed after Russia gas delivery halt

(Alliance News) - Stocks in London ended mixed on Wednesday as sentiment was stifled after Russia announced it would cease gas exports to Bulgaria and Poland, while heavyweight miners kept the FTSE 100's head above water.

UK shareholder meetings calendar - next 7 days

TOP NEWS SUMMARY: Microsoft shares up, Alphabet down after results

(Alliance News) - The following is a summary of top news stories Wednesday.

TOP NEWS: Glaxo posts quarterly profit rise; on track demerging Haleon

(Alliance News) - GlaxoSmithKline PLC on Wednesday reported a higher quarterly profit as it announced it is on track to demerge and list its consumer healthcare arm Haleon.

GSK sales top forecasts

(Sharecast News) - GlaxoSmithKline posted above-forecast numbers on Wednesday, boosted by strong demand for its Covid-19 drug.

LONDON MARKET PRE-OPEN: Lloyds and WPP raise outlook; Aveva cautions

(Alliance News) - Stock prices in London are set to open higher on Wednesday, despite the brutal losses endured in New York overnight, though with sentiment downbeat following mixed US tech earnings and concerns over an escalation of tensions between Russia and the EU.

LONDON BROKER RATINGS: RBC cuts Anglo American; Jefferies ups Berkeley

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

CureVac, GSK's experimental COVID variant vaccine effective in mice -study

FRANKFURT, April 21 (Reuters) - CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies on mice, CureVac said, as it seeks to catch up with rivals' development work.

UK earnings, trading statements calendar - next 7 days

European shares rebound on earnings boost

April 20 (Reuters) - A clutch of positive earnings including from chipmaker ASML and consumer stock Danone, helped European shares rebound on Wednesday, although worries over the Ukraine-Russia war, slowing growth and rising yields kept gains in check.

Drugmaker GlaxoSmithKline faces strike over "derisory" pay offer

(Alliance News) - Hundreds of UK workers at pharmaceutical giant GlaxoSmithKline PLC are set to strike over a "derisory" pay offer way below the level of British inflation, a union said Wednesday.

GlaxoSmithKline says FDA accepts application for kidney disease drug

(Alliance News) - GlaxoSmithKline PLC on Tuesday said the US Food & Drug Administration has accepted the company's application for the review of kidney disease drug daprodustat.